STOCK TITAN

Bespoke Extracts (BSPK) furnishes Q3 2025 results on Form 8-K

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Bespoke Extracts, Inc. filed a Form 8-K to report that it has released a press release covering its financial results and business highlights for the third quarter ended September 30, 2025. The press release, dated November 12, 2025, is attached as Exhibit 99.1 and incorporated by reference. The company states that the information under this item, including the exhibit, is being furnished rather than filed, which limits its exposure to certain Exchange Act liabilities.

Positive

  • None.

Negative

  • None.
Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
false 0001409197 0001409197 2025-11-12 2025-11-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 12, 2025

 

Bespoke Extracts, Inc.
(Exact name of registrant as specified in its charter)

 

Nevada   000-52759   20-4743354
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

12001 E.33rd Ave Unit O

Aurora, CO 80010

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code (720) 949-1143

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 

 
 

 

Item 2.02 Results of Operations and Financial Condition

 

On November 12, 2025, Bespoke Extracts, Inc. (the “Company”) issued a press release announcing its financial results and business highlights for the third quarter ended September 30, 2025. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information set forth under this Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits – The following exhibits are filed as part of this report:

 

Exhibit No.   Description of Exhibit
99.1   Press Release, dated November 12, 2025
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1 
 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Bespoke Extracts, Inc.  
     
Date: November 19, 2025 By: /s/ Michael Feinsod
    Michael Feinsod
Chief Executive Officer

 

 

2

 

 

FAQ

What did Bespoke Extracts, Inc. (BSPK) announce in this Form 8-K?

Bespoke Extracts, Inc. reported that it issued a press release announcing its financial results and business highlights for the third quarter ended September 30, 2025, which is included as Exhibit 99.1.

Which period do the newly announced Bespoke Extracts (BSPK) results cover?

The press release referenced in the Form 8-K covers Bespoke Extracts, Inc.'s third quarter ended September 30, 2025.

Where can investors find the detailed Q3 2025 results for Bespoke Extracts (BSPK)?

Detailed Q3 2025 results and business highlights are contained in Exhibit 99.1 to the Form 8-K, which is the press release dated November 12, 2025.

Is the Bespoke Extracts (BSPK) Q3 2025 information considered filed or furnished?

The company states that the information under Item 2.02, including Exhibit 99.1, is being furnished, not filed, for purposes of Section 18 of the Exchange Act.

Which exhibit is included with this Bespoke Extracts (BSPK) Form 8-K?

The Form 8-K includes Exhibit 99.1, a press release dated November 12, 2025, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.

Who signed the Bespoke Extracts, Inc. Form 8-K for the Q3 2025 results announcement?

The Form 8-K was signed on behalf of Bespoke Extracts, Inc. by Michael Feinsod, the company's Chief Executive Officer.